NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	30/04/2020
Target sample size	452
Countries of recruitment	Japan,Asia except Japan,South America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Nivolumab, Carboplatin, Cisplatin, Paclitaxel, Pemetrexed, Docetaxel Therapeutic category code : 42- Antineoplastic agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Placebo, Carboplatin, Cisplatin, Paclitaxel, Pemetrexed, Docetaxel Therapeutic category code : 42- Antineoplastic agents Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety efficacy

Key inclusion & exclusion criteria

Age minimum	>= 18age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria